MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617049450 A) filed by Trimph Ip Pty Ltd on April 17, 2026, for Biocompatible Polymers For Use In Oncological Imaging And Radiation.
Inventor includes Fathi, Ali.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: Disclosed herein is a polymer for administering at a treatment site to form a hydrogel to physically space/isolate target tissue for radiotherapy, the polymer comprising a first monomer for binding water; a second monomer for imparting mechanical properties; optionally, a third monomer for binding to a natural or synthetic peptide or protein (NSPP); and a fourth monomer for imparting phase-transition behaviour. Preferably, the first monomer is OEGMA; the second monomer is PLA/HEMA; the third monomer is NAS; and the fourth monomer is NIPAAm, and the polymer comprises: OEGMA in an amount of from about 1 to about 15 mol%; PLA/HEMA in an amount of from 5 to about 50 mol%; NAS in an amount of from 0 to about 15 mol%; and NIPAAm in an amount of up to about 85 mol%. Preferably, the target tissue is a human prostate. Preferably, the polymer is administered at a concentration of up to about 280 mg/mL in aqueous solution such as saline.
Disclaimer: Curated by HT Syndication.
